Esperion Aims Low On Price For Cholesterol Drug Bempedoic Acid

Esperion is emphasizing the low list and net price of its oral bempedoic acid for cholesterol reduction, relative to the injectable PCSCK9 inhibitors, but still significantly higher than other oral cholesterol-lowering drugs.

US-Money-and-Pills_V2_1200x675

More from Drug Pricing

More from Scrip